Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin US Core Bond ETF
FLCB
|
+$697M |
| 2 |
Verizon
VZ
|
+$437M |
| 3 |
Merck
MRK
|
+$411M |
| 4 |
Franklin US Treasury Bond ETF
FLGV
|
+$370M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.17B |
| 2 |
RTN
Raytheon Company
RTN
|
+$831M |
| 3 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$566M |
| 4 |
Gilead Sciences
GILD
|
+$499M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$463M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.52% |
| 2 | Healthcare | 15.75% |
| 3 | Financials | 10.84% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Floor & Decor
FND
$5.81B
| $85M | 0.04% |
1,272,143
+62,375
| +5% | +$2.84M |
|
402
HCA Healthcare
HCA
$84.8B
| $84.5M | 0.04% |
689,905
-54,612
| -7% | -$5.68M |
|
403
Broadridge
BR
$17.2B
| $84.4M | 0.04% |
642,899
+169,885
| +36% | +$19.7M |
|
404
CNO Financial Group
CNO
$4.97B
| $84.3M | 0.04% |
5,427,475
+1,769,670
| +48% | +$24.4M |
|
|
SNV
405
DELISTED
Synovus
SNV
| $84.2M | 0.04% |
4,125,857
-195,922
| -5% | -$3.79M |
|
406
PUT
iShares MSCI EAFE ETF
EFA
$76.4B
| $84.2M | 0.04% |
+1,312,600
| New | +$75.9M |
|
407
Crown Holdings
CCK
$12.8B
| $84.1M | 0.04% |
1,188,987
+89,657
| +8% | +$5.64M |
|
408
Essential Utilities
WTRG
$11.2B
| $84M | 0.04% |
1,837,527
+87,527
| +5% | +$3.7M |
|
409
Nasdaq
NDAQ
$52.1B
| $83.9M | 0.04% |
1,877,100
+1,794,774
| +2,180% | +$66.8M |
|
410
Humana
HUM
$46.7B
| $83.8M | 0.04% |
208,341
+19,721
| +10% | +$7.38M |
|
411
CRISPR Therapeutics
CRSP
$4.58B
| $83.6M | 0.04% |
899,521
+456,574
| +103% | +$26.7M |
|
|
RVNC
412
DELISTED
Revance Therapeutics, Inc.
RVNC
| $83.3M | 0.04% |
3,466,888
-224,600
| -6% | -$4.43M |
|
413
Black Hills Corp
BKH
$5.73B
| $83.1M | 0.04% |
1,353,108
+198,159
| +17% | +$12M |
|
414
BJs Wholesale Club
BJ
$11.9B
| $83M | 0.04% |
2,003,402
-365,442
| -15% | -$11.2M |
|
415
Repligen
RGEN
$7.44B
| $83M | 0.04% |
610,734
+230,857
| +61% | +$27.2M |
|
416
AngloGold Ashanti
AU
$40.3B
| $82.6M | 0.04% |
2,515,443
-256,000
| -9% | -$6.33M |
|
417
Church & Dwight Co
CHD
$23.1B
| $82.2M | 0.04% |
965,375
-96,873
| -9% | -$7.05M |
|
418
Allegion
ALLE
$13B
| $82.1M | 0.04% |
735,378
+220
| +0% | +$21.7K |
|
419
Logitech
LOGI
$15.2B
| $81.3M | 0.04% |
1,121,478
-5,529
| -0.5% | -$295K |
|
|
IFFT
420
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $80.9M | 0.04% |
1,742,242
+300,000
| +21% | +$13.8M |
|
421
IQVIA
IQV
$34.7B
| $80.7M | 0.04% |
491,003
-148,785
| -23% | -$20.2M |
|
|
SIVB
422
DELISTED
SVB Financial Group
SIVB
| $79.8M | 0.04% |
359,650
+10,212
| +3% | +$1.97M |
|
423
Teladoc Health
TDOC
$1.58B
| $79.8M | 0.04% |
356,408
+330,256
| +1,263% | +$57.9M |
|
|
HZNP
424
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $79.7M | 0.04% |
+1,326,982
| New | +$56.8M |
|
425
Penumbra
PEN
$12.5B
| $79.6M | 0.04% |
391,447
-2,914
| -0.7% | -$506K |
|
Similar funds
Franklin Resources's Q2 2020 Portfolio in Review
As of Q2 2020, Franklin Resources held 1,773 positions worth $194B, up 30% from $150B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources's Q2 2020 filing shows 304 new, 648 increased, 578 reduced and 97 closed positions. Its largest new stake was Franklin US Treasury Bond ETF: 14,676,171 shares worth $374M. The largest sale was Allergan plc, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Franklin Resources's largest Q2 2020 buy was Franklin US Treasury Bond ETF: 14,676,171 shares worth $374M.
- Franklin Resources added most to Franklin US Core Bond ETF in Q2 2020, an estimated $697M increase.
- Franklin Resources's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $499M.
- Franklin Resources fully exited Allergan plc in Q2 2020, selling an estimated $1.17B.
- Franklin Resources's ten largest holdings make up 13% of its $194B portfolio in Q2 2020.
- Franklin Resources opened 304 new positions and closed 97 in Q2 2020.
- Franklin Resources's portfolio value rose 30% quarter-over-quarter to $194B.
Based on Franklin Resources's 13F filing for Q2 2020, filed 13 Aug 2020.